Unfortunately, India is the world's TB epicentre with over 2.5 million people living with the disease every year. As per World Health Organisation (WHO) Global Tuberculosis Report 2015, for the year 2014, deaths due to TB were estimated in India to be 2,20,000 which is higher than any other country. So to tackle this menace, ahead of World Tuberculosis Day on March 24, the government has launched a drug called Bedaquiline (aka miracle drug) to specifically treat multi-drug resistant TB. It is the first TB drug to be approved by Food and Drug Administration (FDA) in over 40 years. What is this new drug and what does it’s introduction mean for India? This drug is manufactured by the Janssen- the pharma arm of Johnson & Johnson. In coordinated programme between the Indian government and Janssen, the drug has been made available to 600 patients in six public hospitals across the country.